**Question:** Ondansetron acts by:

A. Blocking serotonin receptors
B. Inhibiting the release of histamine
C. Inhibiting acetylcholine release
D. Modulating neurotransmitter synthesis

**Core Concept:** Ondansetron is a selective serotonin receptor antagonist, primarily targeting 5-HT3 receptors. These receptors play a crucial role in the initiation and maintenance of nausea and vomiting.

**Why the Correct Answer is Right:** Ondansetron acts by blocking the serotonin receptors (specifically, 5-HT3 receptors), which are involved in the transmission of nausea and vomiting signals in the gastrointestinal tract. By inhibiting these receptors, ondansetron effectively counteracts the nausea and vomiting symptoms.

**Why Each Wrong Option is Incorrect:**

A. Blocking serotonin receptors is not the primary action of ondansetron, as explained above.
B. Histamine is not directly involved in the initiation of nausea and vomiting, making this option incorrect.
C. Acetylcholine is not the primary neurotransmitter responsible for nausea and vomiting, making this option irrelevant to the correct action of ondansetron.
D. Ondansetron does not modulate neurotransmitter synthesis; its primary action is receptor blocking, as explained above.

**Clinical Pearl:** Ondansetron is a valuable medication in the management of nausea and vomiting associated with chemotherapy, radiation therapy, and post-operative care. By blocking the 5-HT3 receptors, it effectively reduces nausea and vomiting symptoms, improving patient comfort and recovery.